BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Diagnosis
18 results:

  • 1. colorectal cancer-secreted exosomal circ_001422 plays a role in regulating kdr expression and activating mTOR signaling in endothelial cells by targeting miR-195-5p.
    Ghafouri I; Pakravan K; Razmara E; Montazeri M; Rouhollah F; Babashah S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12227-12240. PubMed ID: 37432457
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Retrospective Analysis of Treatment Pathways in Patients With BRAF
    Gerger A; Eisterer W; Fuxius S; Bastian S; Koeberle D; Welslau M; Sanoyan DA; Maas C; Uhlig J; Fenchel K; Greil R; VON DER Heyde E; Agocs GR; Weide R; Schwager M; Reichenbach F; Modest DP; Fritsch R
    Anticancer Res; 2022 Oct; 42(10):4773-4785. PubMed ID: 36191968
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
    Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
    Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Intestinal Perforation in a Patient with Colon cancer during Treatment with Regorafenib: A Case Report and Review of the Literature.
    Ouchi R; Okada K; Usui K; Kurata N; Suzuki S; Nagao M; Watanabe Y; Koyama K
    Tohoku J Exp Med; 2021 Jul; 254(3):207-211. PubMed ID: 34321384
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. colorectal cancer Biology, diagnosis, and Therapeutic Approaches.
    Dariya B; Aliya S; Merchant N; Alam A; Nagaraju GP
    Crit Rev Oncog; 2020; 25(2):71-94. PubMed ID: 33389859
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
    Pires-Luis AS; Martinek P; Alaghehbandan R; Trpkov K; Comperat EM; Perez Montiel DM; Bulimbasic S; Lobo J; Henrique R; Vanecek T; Pivovarcikova K; Michalova K; Pitra T; Hora M; Marques A; Lopes JM; Rogala J; Mareckova J; Michal M; Hes O
    Adv Anat Pathol; 2020 Sep; 27(5):303-310. PubMed ID: 32520749
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Role of intravoxel incoherent motion MRI in preoperative evaluation of DNA mismatch repair status in rectal cancers.
    Yan C; Liu S; Pan X; Chen G; Ge W; Guan W; Liu S; Li M; He J; Zhou Z
    Clin Radiol; 2019 Oct; 74(10):814.e21-814.e28. PubMed ID: 31427042
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Looking back 2018--focused on colorectal cancer].
    Cai J; Wang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):9-16. PubMed ID: 30703787
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
    Liu Y; Li Y; Hou R; Shu Z
    J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without kdr mutation: A case report.
    Rosati G; Del Gaudio N; Scarano E; Cifarelli RA; Altucci L; Bilancia D
    Medicine (Baltimore); 2018 Jun; 97(25):e11178. PubMed ID: 29924031
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CCL24 contributes to HCC malignancy via RhoB- VEGFA-vegfr2 angiogenesis pathway and indicates poor prognosis.
    Jin L; Liu WR; Tian MX; Jiang XF; Wang H; Zhou PY; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
    Oncotarget; 2017 Jan; 8(3):5135-5148. PubMed ID: 28042950
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
    Avallone A; Piccirillo MC; Aloj L; Nasti G; Delrio P; Izzo F; Di Gennaro E; Tatangelo F; Granata V; Cavalcanti E; Maiolino P; Bianco F; Aprea P; De Bellis M; Pecori B; Rosati G; Carlomagno C; Bertolini A; Gallo C; Romano C; Leone A; Caracò C; de Lutio di Castelguidone E; Daniele G; Catalano O; Botti G; Petrillo A; Romano GM; Iaffaioli VR; Lastoria S; Perrone F; Budillon A
    BMC Cancer; 2016 Feb; 16():69. PubMed ID: 26857924
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunohistochemical and molecular features of primary clear cell-adenocarcinoma of the rectum, as predictive factors for individualized therapy.
    Gurzu S; Jung I; Bara T; Bara T; Serester O
    Rom J Morphol Embryol; 2014; 55(2 Suppl):629-33. PubMed ID: 25178336
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. VEGFA, FLT1, kdr and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
    Slattery ML; Lundgreen A; Wolff RK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E140-50. PubMed ID: 23794399
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tyrosine kinase expression in pulmonary metastases and paired primary tumors.
    Muehling BM; Toelkes S; Schelzig H; Barth TF; Sunder-Plassmann L
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):228-31. PubMed ID: 19948538
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Case report of extrarenal rhabdoid tumor of pelvic retroperitoneum molecular profile of angiogenesis and its implication in new treatment strategy.
    Cai G; Zhu X; Xu Y; Du X; Zhang Z; Zhang Y; Chen T; Zhou X; Guan Z; Cai S
    Cancer Biol Ther; 2009 Mar; 8(5):417-21. PubMed ID: 19276648
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).
    Ponti G; Losi L; Pellacani G; Rossi GB; Presutti L; Mattioli F; Villari D; Wannesson L; Alicandri Ciufelli M; Izzo P; De Rosa M; Marone P; Seidenari S
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):173-8. PubMed ID: 18227724
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.